Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook Life Science Investing
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results Life Science Investing
Immunome Reports Second Quarter 2026 Financial Results and Provides Business Update Life Science Investing
AbCellera Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Life Science Investing
Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights Life Science Investing
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update Pharmaceutical Investing
Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity Life Science Investing
Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update Life Science Investing
